Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co. Ltd. (TGRNF) Stock Competitors & Peer Comparison
See (TGRNF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TGRNF | $0.62 | +0.00% | 790.8M | 10.29 | $0.06 | +4.02% |
| RHHVF | $316.57 | -0.07% | 255.4B | 21.73 | $14.57 | +3.48% |
| RHHBF | $333.00 | -4.86% | 253.5B | 22.88 | $14.57 | +3.30% |
| RHHBY | $38.84 | -0.38% | 252.8B | 21.30 | $1.82 | +3.53% |
| AZNCF | $147.50 | +0.07% | 228.7B | 27.78 | $5.31 | +2.09% |
| NVSEF | $118.50 | +2.16% | 224.9B | 17.27 | $6.86 | +3.34% |
| SNYNF | $92.56 | -0.04% | 112.9B | 15.99 | $5.79 | +4.73% |
| BMYMP | $785.00 | -4.85% | 93.6B | 3488.89 | $0.23 | +0.13% |
| CHGCF | $51.09 | +0.18% | 84.1B | 31.34 | $1.63 | +2.29% |
| CHGCY | $24.56 | +1.99% | 80.7B | 30.27 | $0.81 | +2.19% |
Stock Comparison
TGRNF vs RHHVF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, RHHVF has a market cap of 255.4B. Regarding current trading prices, TGRNF is priced at $0.62, while RHHVF trades at $316.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas RHHVF's P/E ratio is 21.73. In terms of profitability, TGRNF's ROE is +0.09%, compared to RHHVF's ROE of +0.35%. Regarding short-term risk, TGRNF is more volatile compared to RHHVF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check RHHVF's competition here
TGRNF vs RHHBF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, RHHBF has a market cap of 253.5B. Regarding current trading prices, TGRNF is priced at $0.62, while RHHBF trades at $333.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas RHHBF's P/E ratio is 22.88. In terms of profitability, TGRNF's ROE is +0.09%, compared to RHHBF's ROE of +0.35%. Regarding short-term risk, TGRNF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check RHHBF's competition here
TGRNF vs RHHBY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, RHHBY has a market cap of 252.8B. Regarding current trading prices, TGRNF is priced at $0.62, while RHHBY trades at $38.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas RHHBY's P/E ratio is 21.30. In terms of profitability, TGRNF's ROE is +0.09%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, TGRNF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check RHHBY's competition here
TGRNF vs AZNCF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, AZNCF has a market cap of 228.7B. Regarding current trading prices, TGRNF is priced at $0.62, while AZNCF trades at $147.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas AZNCF's P/E ratio is 27.78. In terms of profitability, TGRNF's ROE is +0.09%, compared to AZNCF's ROE of +0.19%. Regarding short-term risk, TGRNF is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check AZNCF's competition here
TGRNF vs NVSEF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, NVSEF has a market cap of 224.9B. Regarding current trading prices, TGRNF is priced at $0.62, while NVSEF trades at $118.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas NVSEF's P/E ratio is 17.27. In terms of profitability, TGRNF's ROE is +0.09%, compared to NVSEF's ROE of +0.31%. Regarding short-term risk, TGRNF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check NVSEF's competition here
TGRNF vs SNYNF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, SNYNF has a market cap of 112.9B. Regarding current trading prices, TGRNF is priced at $0.62, while SNYNF trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas SNYNF's P/E ratio is 15.99. In terms of profitability, TGRNF's ROE is +0.09%, compared to SNYNF's ROE of +0.10%. Regarding short-term risk, TGRNF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check SNYNF's competition here
TGRNF vs BMYMP Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, BMYMP has a market cap of 93.6B. Regarding current trading prices, TGRNF is priced at $0.62, while BMYMP trades at $785.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas BMYMP's P/E ratio is 3488.89. In terms of profitability, TGRNF's ROE is +0.09%, compared to BMYMP's ROE of +0.32%. Regarding short-term risk, TGRNF is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check BMYMP's competition here
TGRNF vs CHGCF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, CHGCF has a market cap of 84.1B. Regarding current trading prices, TGRNF is priced at $0.62, while CHGCF trades at $51.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas CHGCF's P/E ratio is 31.34. In terms of profitability, TGRNF's ROE is +0.09%, compared to CHGCF's ROE of +0.17%. Regarding short-term risk, TGRNF is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check CHGCF's competition here
TGRNF vs CHGCY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, CHGCY has a market cap of 80.7B. Regarding current trading prices, TGRNF is priced at $0.62, while CHGCY trades at $24.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas CHGCY's P/E ratio is 30.27. In terms of profitability, TGRNF's ROE is +0.09%, compared to CHGCY's ROE of +0.17%. Regarding short-term risk, TGRNF is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check CHGCY's competition here
TGRNF vs GLAXF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, GLAXF has a market cap of 75.7B. Regarding current trading prices, TGRNF is priced at $0.62, while GLAXF trades at $19.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas GLAXF's P/E ratio is 17.05. In terms of profitability, TGRNF's ROE is +0.09%, compared to GLAXF's ROE of +0.22%. Regarding short-term risk, TGRNF is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check GLAXF's competition here
TGRNF vs DSNKY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, DSNKY has a market cap of 46.1B. Regarding current trading prices, TGRNF is priced at $0.62, while DSNKY trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas DSNKY's P/E ratio is 23.48. In terms of profitability, TGRNF's ROE is +0.09%, compared to DSNKY's ROE of +0.18%. Regarding short-term risk, TGRNF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check DSNKY's competition here
TGRNF vs DSKYF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, DSKYF has a market cap of 45.1B. Regarding current trading prices, TGRNF is priced at $0.62, while DSKYF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas DSKYF's P/E ratio is 23.18. In terms of profitability, TGRNF's ROE is +0.09%, compared to DSKYF's ROE of +0.18%. Regarding short-term risk, TGRNF is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check DSKYF's competition here
TGRNF vs BAYRY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, BAYRY has a market cap of 31.9B. Regarding current trading prices, TGRNF is priced at $0.62, while BAYRY trades at $8.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas BAYRY's P/E ratio is -8.46. In terms of profitability, TGRNF's ROE is +0.09%, compared to BAYRY's ROE of -0.10%. Regarding short-term risk, TGRNF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check BAYRY's competition here
TGRNF vs OTSKY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, OTSKY has a market cap of 27.2B. Regarding current trading prices, TGRNF is priced at $0.62, while OTSKY trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas OTSKY's P/E ratio is 9.79. In terms of profitability, TGRNF's ROE is +0.09%, compared to OTSKY's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check OTSKY's competition here
TGRNF vs OTSKF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, OTSKF has a market cap of 23.4B. Regarding current trading prices, TGRNF is priced at $0.62, while OTSKF trades at $44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas OTSKF's P/E ratio is 8.71. In terms of profitability, TGRNF's ROE is +0.09%, compared to OTSKF's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check OTSKF's competition here
TGRNF vs ORINY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, ORINY has a market cap of 22.6B. Regarding current trading prices, TGRNF is priced at $0.62, while ORINY trades at $40.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas ORINY's P/E ratio is 26.32. In terms of profitability, TGRNF's ROE is +0.09%, compared to ORINY's ROE of +0.37%. Regarding short-term risk, TGRNF is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check ORINY's competition here
TGRNF vs GIKLY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, GIKLY has a market cap of 20.2B. Regarding current trading prices, TGRNF is priced at $0.62, while GIKLY trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas GIKLY's P/E ratio is 53.46. In terms of profitability, TGRNF's ROE is +0.09%, compared to GIKLY's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check GIKLY's competition here
TGRNF vs ALPMY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, ALPMY has a market cap of 18.9B. Regarding current trading prices, TGRNF is priced at $0.62, while ALPMY trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas ALPMY's P/E ratio is 55.63. In terms of profitability, TGRNF's ROE is +0.09%, compared to ALPMY's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check ALPMY's competition here
TGRNF vs ALPMF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, ALPMF has a market cap of 18.7B. Regarding current trading prices, TGRNF is priced at $0.62, while ALPMF trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas ALPMF's P/E ratio is 55.05. In terms of profitability, TGRNF's ROE is +0.09%, compared to ALPMF's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check ALPMF's competition here
TGRNF vs CSPCY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, CSPCY has a market cap of 14.4B. Regarding current trading prices, TGRNF is priced at $0.62, while CSPCY trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas CSPCY's P/E ratio is 23.71. In terms of profitability, TGRNF's ROE is +0.09%, compared to CSPCY's ROE of +0.18%. Regarding short-term risk, TGRNF is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check CSPCY's competition here
TGRNF vs RCDTF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, RCDTF has a market cap of 13.5B. Regarding current trading prices, TGRNF is priced at $0.62, while RCDTF trades at $65.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas RCDTF's P/E ratio is 29.08. In terms of profitability, TGRNF's ROE is +0.09%, compared to RCDTF's ROE of +0.22%. Regarding short-term risk, TGRNF is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check RCDTF's competition here
TGRNF vs CHJTF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, TGRNF is priced at $0.62, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, TGRNF's ROE is +0.09%, compared to CHJTF's ROE of +0.18%. Regarding short-term risk, TGRNF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check CHJTF's competition here
TGRNF vs ORINF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, ORINF has a market cap of 11.4B. Regarding current trading prices, TGRNF is priced at $0.62, while ORINF trades at $81.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas ORINF's P/E ratio is 26.14. In terms of profitability, TGRNF's ROE is +0.09%, compared to ORINF's ROE of +0.37%. Regarding short-term risk, TGRNF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check ORINF's competition here
TGRNF vs GIFOF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, GIFOF has a market cap of 9.1B. Regarding current trading prices, TGRNF is priced at $0.62, while GIFOF trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas GIFOF's P/E ratio is 17.28. In terms of profitability, TGRNF's ROE is +0.09%, compared to GIFOF's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check GIFOF's competition here
TGRNF vs GIFLF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, GIFLF has a market cap of 8.4B. Regarding current trading prices, TGRNF is priced at $0.62, while GIFLF trades at $13.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas GIFLF's P/E ratio is 27.25. In terms of profitability, TGRNF's ROE is +0.09%, compared to GIFLF's ROE of +0.03%. Regarding short-term risk, TGRNF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check GIFLF's competition here
TGRNF vs KYKOF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, KYKOF has a market cap of 8.4B. Regarding current trading prices, TGRNF is priced at $0.62, while KYKOF trades at $17.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas KYKOF's P/E ratio is 24.24. In terms of profitability, TGRNF's ROE is +0.09%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, TGRNF is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check KYKOF's competition here
TGRNF vs DPHAY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, TGRNF is priced at $0.62, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, TGRNF's ROE is +0.09%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, TGRNF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check DPHAY's competition here
TGRNF vs OPHLF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, OPHLF has a market cap of 5.2B. Regarding current trading prices, TGRNF is priced at $0.62, while OPHLF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas OPHLF's P/E ratio is 15.42. In terms of profitability, TGRNF's ROE is +0.09%, compared to OPHLF's ROE of +0.06%. Regarding short-term risk, TGRNF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check OPHLF's competition here
TGRNF vs OPHLY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, OPHLY has a market cap of 5.2B. Regarding current trading prices, TGRNF is priced at $0.62, while OPHLY trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas OPHLY's P/E ratio is 15.25. In terms of profitability, TGRNF's ROE is +0.09%, compared to OPHLY's ROE of +0.06%. Regarding short-term risk, TGRNF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check OPHLY's competition here
TGRNF vs PTKFF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, PTKFF has a market cap of 4.4B. Regarding current trading prices, TGRNF is priced at $0.62, while PTKFF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas PTKFF's P/E ratio is N/A. In terms of profitability, TGRNF's ROE is +0.09%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, TGRNF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check PTKFF's competition here
TGRNF vs SNPHF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, SNPHF has a market cap of 3.9B. Regarding current trading prices, TGRNF is priced at $0.62, while SNPHF trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas SNPHF's P/E ratio is 16.36. In terms of profitability, TGRNF's ROE is +0.09%, compared to SNPHF's ROE of +0.12%. Regarding short-term risk, TGRNF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check SNPHF's competition here
TGRNF vs SNPHY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, SNPHY has a market cap of 3.8B. Regarding current trading prices, TGRNF is priced at $0.62, while SNPHY trades at $11.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas SNPHY's P/E ratio is 15.98. In terms of profitability, TGRNF's ROE is +0.09%, compared to SNPHY's ROE of +0.12%. Regarding short-term risk, TGRNF is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check SNPHY's competition here
TGRNF vs VRBCF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, VRBCF has a market cap of 2.9B. Regarding current trading prices, TGRNF is priced at $0.62, while VRBCF trades at $346.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas VRBCF's P/E ratio is 17.21. In terms of profitability, TGRNF's ROE is +0.09%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, TGRNF is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check VRBCF's competition here
TGRNF vs HAWPF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, HAWPF has a market cap of 2.1B. Regarding current trading prices, TGRNF is priced at $0.62, while HAWPF trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas HAWPF's P/E ratio is 11.75. In terms of profitability, TGRNF's ROE is +0.09%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, TGRNF is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check HAWPF's competition here
TGRNF vs HAWPY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, HAWPY has a market cap of 1.6B. Regarding current trading prices, TGRNF is priced at $0.62, while HAWPY trades at $28.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas HAWPY's P/E ratio is 14.25. In terms of profitability, TGRNF's ROE is +0.09%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, TGRNF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check HAWPY's competition here
TGRNF vs CMOPF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, CMOPF has a market cap of 1.2B. Regarding current trading prices, TGRNF is priced at $0.62, while CMOPF trades at $75.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas CMOPF's P/E ratio is 7.97. In terms of profitability, TGRNF's ROE is +0.09%, compared to CMOPF's ROE of +0.14%. Regarding short-term risk, TGRNF is more volatile compared to CMOPF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check CMOPF's competition here
TGRNF vs LYPHF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, LYPHF has a market cap of 1B. Regarding current trading prices, TGRNF is priced at $0.62, while LYPHF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas LYPHF's P/E ratio is 13.40. In terms of profitability, TGRNF's ROE is +0.09%, compared to LYPHF's ROE of +0.06%. Regarding short-term risk, TGRNF is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check LYPHF's competition here
TGRNF vs JCRRF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, JCRRF has a market cap of 609.3M. Regarding current trading prices, TGRNF is priced at $0.62, while JCRRF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas JCRRF's P/E ratio is -19.23. In terms of profitability, TGRNF's ROE is +0.09%, compared to JCRRF's ROE of -0.01%. Regarding short-term risk, TGRNF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check JCRRF's competition here
TGRNF vs MAYNF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, MAYNF has a market cap of 285.6M. Regarding current trading prices, TGRNF is priced at $0.62, while MAYNF trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas MAYNF's P/E ratio is -3.48. In terms of profitability, TGRNF's ROE is +0.09%, compared to MAYNF's ROE of -0.35%. Regarding short-term risk, TGRNF is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check MAYNF's competition here
TGRNF vs PTKFY Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, PTKFY has a market cap of 21M. Regarding current trading prices, TGRNF is priced at $0.62, while PTKFY trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas PTKFY's P/E ratio is 20.73. In terms of profitability, TGRNF's ROE is +0.09%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, TGRNF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check PTKFY's competition here
TGRNF vs PSYGF Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, PSYGF has a market cap of 1.7M. Regarding current trading prices, TGRNF is priced at $0.62, while PSYGF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas PSYGF's P/E ratio is -0.02. In terms of profitability, TGRNF's ROE is +0.09%, compared to PSYGF's ROE of +2.78%. Regarding short-term risk, TGRNF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for TGRNF.Check PSYGF's competition here
TGRNF vs CRXTQ Comparison August 2025
TGRNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TGRNF stands at 790.8M. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, TGRNF is priced at $0.62, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TGRNF currently has a P/E ratio of 10.29, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, TGRNF's ROE is +0.09%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, TGRNF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for TGRNF.Check CRXTQ's competition here